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Abstract
Background: Palm olein oil (PO), obtained from refining of palm oil is rich in monounsaturated fatty acid
and antioxidant vitamins and is widely used as oil in diet in many parts of the world including India. Palm
oil has been reported to have beneficial effects in oxidative stress associated with hypertension and arterial
thrombosis. Oxidative stress plays a major role in the etiopathology of myocardial ischemic-reperfusion
injury (IRI) which is a common sequel of ischemic heart disease. Antioxidants have potent therapeutic
effects on both ischemic heart disease and ischemic-reperfusion injury. Information on the effect of PO on
ischemic-reperfusion injury is, however, lacking. In the present study, the effect of dietary palm olein oil
on oxidative stress associated with IRI was investigated in an isolated rat heart model. Wistar rats (150–
200 gm) of either sex were divided into three different groups (n = 16). Rats were fed with palm olein oil
supplemented commercial rat diet, in two different doses [5% v / w (PO 5) and 10% v / w (PO 10) of diet]
for 30 days. Control rats (C) were fed with normal diet. After 30 days, half the rats from each group were
subjected to in vitro myocardial IRI (20 min of global ischemia, followed by 40 min of reperfusion). Hearts
from all the groups were then processed for biochemical and histopathological studies. One way ANOVA
followed by Bonferroni test was applied to test for significance and values are expressed as mean ± SE (p
< 0.05).
Results: There was a significant increase in myocardial catalase (CAT), superoxide dismutase (SOD) and
glutathione peroxidase (GPx) activities with no significant change in myocardial thiobarbituric acid reactive
substances (TBARS) only in group PO 5 as compared to group C. There was no light microscopic evidence
of tissue injury. A significant rise in myocardial TBARS and depletion of myocardial endogenous
antioxidants (SOD, CAT and GPx) along with significant myocyte injury was observed in control rats
subjected to ischemia-reperfusion (C IR). Hearts from palm olein oil fed rats subjected to ischemia-
reperfusion (PO 5 IR and PO 10 IR) were protected from increase in TBARS and depletion of endogenous
antioxidants as compared to C IR group. No significant myocyte injury was present in the treated groups.
Conclusions: The present study demonstrated for the first time that dietary palm olein oil protected rat
heart from oxidative stress associated with ischemic-reperfusion injury.
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Background
Ischemic heart disease (IHD) is a major cause of death all
over the world. Reduction in the blood flow to myocar-
dium leads to IHD and its restitution (reperfusion), spon-
taneously or by drug / surgery, is essential for tissue/organ
survival. However, reperfusion itself exacerbates myocar-
dial injury, commonly known as myocardial ischemic-
reperfusion injury (IRI) [1]. Therefore, IRI is considered as
a common sequel of IHD. Oxidative stress has been
largely implicated in the etiopathogenesis of IRI. Oxida-
tive stress occurs due to increased production of reactive
oxygen species (ROS) like, superoxide radical, hydrogen
peroxide, hydroxyl radical at the time of reperfusion,
which overwhelms the endogenous antioxidant defense
[2]. Interaction of ROS with cell membrane and various
other cellular components have deleterious effects on cel-
lular functions and viability. Oxidative stress is evidenced
by increased cellular accumulation of lipid peroxides and
depletion of endogenous antioxidants [3-5].
Living organisms have developed antioxidant defense
mechanisms against damage due to oxidative stress. These
mechanisms in the heart have been extensively studied
and the most active endogenous antioxidants involved in
this process are superoxide dismutase (SOD), catalase
(CAT), and glutathione peroxidase (GPx) [2,6]. In addi-
tion to this, alpha-tocopherols or vit E, vitamin C and
beta-carotene constitute important exogenous antioxi-
dants present in diet [7,8].
The physiological actions of diet continue to be the focus
of interest because of its major role in ischemic heart dis-
ease. Dietary antioxidants e.g., vitamin E, beta-carotene,
vitamin C have beneficial effects in oxidative stress associ-
ated with various cardiovascular diseases, including
ischemic heart disease [9-11]. Therefore, dietary antioxi-
dants have potential therapeutic role in the prevention
and treatment of ischemic heart disease.
Palm oil, obtained from the fruit of the tropical plant
Elaeis guineensis, is the second major edible oil used world-
wide [12]. Palm olein oil (PO), a liquid fraction obtained
from the refining of palm oil, is rich in oleic acid (42.7–
43.9%), beta-carotene and vitamin E (tocopherols and
tocotrienols). PO is used as dietary oil in many parts of the
world including India. In some previous studies, palm oil
has been reported to have antioxidant effects in hyperten-
sion [13,14] and arterial thrombosis [15] in rats. In addi-
tion to this, palm oil has been shown to increase
prostacyclin (PGI2) and reduce thromboxane A2 (TXA2)
levels in tissues [16]. However scientific studies on anti-
oxidant effects of palm olein oil on ischemic heart disease
and ischemic-reperfusion injury are still lacking.
Therefore, the present study was designed to evaluate the
effects of dietary palm olein oil on myocardial endog-
enous antioxidants and on oxidative stress associated with
ischemic-reperfusion injury in isolated rat heart model.
Results
There was no mortality, changes in body weight as well as
food and water intake pattern of rats in any group.
Biochemical parameters
I. Changes in the basal level of myocardial lipid peroxidation and 
endogenous antioxidants (Table 1)
I.a. Basal myocardial TBARS levels
There were no significant changes in myocardial TBARS
levels in both PO5 (8.5 ± 0.8 nmol / mg protein) and
PO10 (8.2 ± 1.2 nmol / mg protein) groups when com-
pared to that of control group (7.8 ± 0.4 nmol / mg
protein).
I.b. Basal myocardial catalase (CAT) activity
There was a significant increase in myocardial CAT activity
in both PO5 (50.2 ± 3.5 units / mg protein; p < 0.01) and
PO10 (45.6 ± 4.0 units / mg protein; p < 0.05) groups as
compared to that of control group (34.4 ± 2.1 units / mg
protein).
Table 1: Effect of dietary palm olein oil on myocardial TBARS, catalase, SOD, and GPx levels in different groups
Group TBARS (nmol/mg protein) CATALASE (U/mg protein SOD (U/mg protein GPx (U/mg protein)
Control 7.8 ± 0.4 34.4 ± 2.1 3.5 ± 0.08 0.13 ± 0.01
Control IR 9.4 ± 0.3* 29.1 ± 0.8* 3.01 ± 0.15* 0.11 ± 0.002**
PO 5 8.5 ± 0.8 50.2 ± 3.5** 5.6 ± 0.5** 0.18 ± 0.01**
PO 10 8.2 ± 1.2 45.6 ± 4.0* 3.8 ± 0.3 0.16 ± 0.02
PO 5 IR 6.8 ± 0.4+++ 56.9 ± 4.4+++ 3.1 ± 0.2 0.12 ± 0.01
PO 10 IR 5.9 ± 0.6+++ 36.3 ± 5.6 3.4 ± 0.3 0.15 ± 0.01++
All values are expressed as Mean ± SE (n = 6)
p values: * < 0.05; ** < 0.01; vs Control; ++ < 0.01; +++ < 0.001 vs Control IR (one way ANOVA)BMC Pharmacology 2004, 4:29 http://www.biomedcentral.com/1471-2210/4/29
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I.c. Basal myocardial superoxide dismutase (SOD) activity
There were a significant increase in myocardial SOD activ-
ity in PO 5 (5.6 ± 0.5 units / mg protein; p < 0.01) group
when compared to that of the control group (3.5 ± 0.08
units / mg protein). There was no significant change in
myocardial SOD activity in PO10 (3.8 ± 0.3 units / mg
protein) group.
I.d. Basal myocardial glutathione peroxidase (GPx) activity
There was a significant (p < 0.01) increase in myocardial
GPx activity in PO5 (0.18 ± 0.01 units / mg protein) group
when compared to that of the control group (0.13 ± 0.01
units / mg protein). There was no significant change in
myocardial GPx activity in PO10 (0.16 ± 0.02 units / mg
protein) group.
II. Changes in myocardial lipid peroxidation and endogenous 
antioxidants following ischemic-reperfusion injury (Table 1)
II.a. Myocardial TBARS levels after ischemic-reperfusion injury
There was a significant (p < 0.05) increase in myocardial
TBARS level in the C IR group (9.4 ± 0.3 nmol / mg pro-
tein) when compared to that of the control group (7.8 ±
0.4 nmol / mg protein). There was a significant (p < 0.01)
decrease in myocardial TBARS levels in both PO5 IR (6.8
± 0.4 nmol / mg protein) and PO10 IR (5.9 ± 0.6 nmol /
mg protein) groups when compared to that of the C IR
group.
II.b. Myocardial CAT activity after ischemic-reperfusion injury
There was a significant (p < 0.05) decrease in myocardial
CAT activity (29.1 ± 0.8 units / mg protein) in C IR group
when compared to that of the control group (34.4 ± 2.1
units / mg protein). There was a significant rise in CAT
activity in PO5 IR (56.9 ± 4.4 units / mg protein; p <
0.001) group with no significant change in PO10 IR (36.3
± 5.6 units / mg protein) group when compared to C IR
group.
II.c. Myocardial SOD activity after ischemic-reperfusion injury
There was a significant decrease in myocardial SOD activ-
ity in C IR group (3.01 ± 0.15 units / mg protein; p < 0.05)
as compared to control group (3.5 ± 0.08 units / mg pro-
tein). No significant changes in SOD activities were
observed in both PO5 IR (3.1 ± 0.2 units / mg protein)
and PO10 IR (3.4 ± 0.3 units / mg protein) groups as com-
pared to C IR group.
II.d. Myocardial GPx activity after ischemic-reperfusion injury
There was a significant (p < 0.01) decrease in myocardial
GPx activity in C IR group (0.11 ± 0.002 units / mg pro-
tein) as compared to control group (0.13 ± 0.004 units /
mg protein). There was no significant change in myocar-
dial GPx activity in PO5 IR group (0.12 ± 0.01 units / mg
protein) with a significant (p < 0.01) increase in myocar-
dial GPx activity in PO10 IR group (0.15 ± 0.01 units / mg
protein) as compared to C IR group.
Histopathological study
Fig. 1 shows the H&E micrograph of control heart with
normal architecture. In PO5 and PO10 groups there was
no evidence of cellular injury (not shown). Focal loss of
myocardial fibres and marked edema was observed in C
IR group (Fig. 2). Mild to moderate edema was observed
in PO10 IR group (Fig. 4). Degree of edema was reduced
in PO5 IR with no evidence of focal necrosis (Fig. 3)
Discussion
In the present study, a significant increase in myocardial
SOD, catalase and GPx activity was observed in the lower
dose of palm olein oil fed rats. However, their further aug-
mentation was not observed in the higher dose, i.e., a dose
dependent effect was not observed. The finding correlates
with the previous studies in which an increase in response
was not observed with the increase in the dose of supple-
mented vitamin E [26,27]. The possible reasons behind
the lack of dose response relationship may be a decrease
in intestinal absorption as a result of increase in dose [28]
and newly absorbed vitamin E in part replacing the alpha-
tocopherol in circulating lipoproteins [29].
Augmentation of endogenous antioxidants (SOD, CAT,
GPx) has been recognized as an important pharmacolog-
ical property, present in natural as well as many synthetic
compounds [30-33]. This constitutes a major mechanism
of protection against oxidative stress, offered by them
[30,35,37]. The most abundant reactive oxygen species
generated in living system is superoxide radical which is
acted upon by SOD to produce hydrogen peroxide which
in turn is inactivated by catalase and / or GPx into water
and oxygen. Thus an increase in both SOD and catalase
along with GPx activity is considered to be more benefi-
cial in the event of oxidative stress [34].
Increase in myocardial TBARS and depletion of myocar-
dial endogenous antioxidants support the occurrence of
oxidative stress in the control hearts following ischemia-
reperfusion in the present study. It was also accompanied
by tissue injury with marked edema and focal loss of myo-
cardial fibres. Similar changes have been reported earlier
to occur following brief period of ischemia followed by
reperfusion in rat heart [35-37]. Hearts from palm olein
oil fed rats in both doses were protected against oxidative
stress, as evidenced by inhibition of increase in TBARS,
depletion of catalase, GPx and tissue injury following
ischemia-reperfusion. In a previous study, palm oil has
been reported to prevent oxidative stress induced hyper-
tension in rats [13]. The mechanism of such protection
can be attributed to the augmented endogenous antioxi-
dant reserve of heart in the lower dose. However, theBMC Pharmacology 2004, 4:29 http://www.biomedcentral.com/1471-2210/4/29
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higher dose, which did not cause any significant augmen-
tation of endogenous antioxidants, also inhibited deple-
tion of antioxidants, rise in TBARS and tissue injury. It is
possible that direct antioxidant effects of palm olein oil
may be attributable to the presence of alpha tocopherols
and tocotrienols, which are known to protect against oxi-
dative stress.
Experimental as well as clinical studies with exogenous
antioxidants supplementation have been shown to have
protective effect in ischemic heart disease [38,39]. In this
regard, the most commonly used exogenous antioxidants
are vitamin E (tocopherols and tocotrienols), beta-caro-
tene and vitamin C. Palm oil is also beneficial in condi-
tions like hypertension [13,14,40], arterial thrombosis
[15,41] and causes increase in PGI2 /TXA2 ratio [16]. Palm
oil derived vitamin E rich in tocotrienols has shown ben-
eficial effects against hypercholesterolemia [42,43] and is
considered to be more potent than tocopherols [44].
The observations made in the present study have impor-
tant nutritional significance for palm olein oil in relation
to ischemic heart disease. However, further studies are
required to establish the mechanism, underlying the aug-
mentation of tissue antioxidants.
Conclusions
The present study, for the first time, demonstrated that
long term oral supplementation of palm olein oil caused
augmentation of endogenous antioxidants of heart,
which were subsequently protected from developing oxi-
dative stress following ischemia-reperfusion.
Light micrograph of heart tissue Figure 1
Light micrograph of heart tissue. Control rat heart (C) showing normal architecture (H & E X 10).BMC Pharmacology 2004, 4:29 http://www.biomedcentral.com/1471-2210/4/29
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Methods
Preparation of diet
Palm olein oil (Ruchi Gold, India) was obtained from the
local market. Commercial rat diet (Ashirwad, India) con-
taining protein: 24%, fat: 5%, fiber: 4%, carbohydrates:
55%, calcium: 0.6%, phosphorus: 0.3% w / w was supple-
mented with palm olein oil in two different doses [5 % v
/ w and 10 %v / w of diet]. The doses were selected from
the previous studies [13,17]. Diet and water were pro-
vided ad libitum.
Animals
The study was approved by Institute Animal Ethics Com-
mittee (245 / IAEC / 04) and all animal care and experi-
mental protocols were in compliance with the NIH
guidelines for the care and use of the Laboratory Animals
(NIH Publication #85–23, 1985). Laboratory bred Wistar
rats (150–200 gm) of either sex were maintained under
standard laboratory conditions at temperature 25 ± 2°C,
relative humidity 50 ± 15% and normal photo period (12
h dark / 12 h light) was used for the study.
Light micrograph of heart tissue Figure 2
Light micrograph of heart tissue. Control rat heart subjected to 20 min ischemia and 40 min reperfusion (C IR) showing 
marked edema and focal destruction of myocardial fibres (H & E X 10).BMC Pharmacology 2004, 4:29 http://www.biomedcentral.com/1471-2210/4/29
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Chemicals
All chemicals were of analytical grade and chemicals
required for sensitive biochemical assays were obtained
from Sigma Chemicals (St. Louis, USA). Double distilled
water (DDW) was used in all biochemical assays.
Experimental protocol
After one week of acclimatization, rats were randomly
divided into three groups, each group containing 16 rats.
In control group (C), rats were fed with normal diet for 30
days. In groups (PO5 and PO10), rats were fed with palm
olein oil supplemented commercial rat diet for 30 days in
two different doses; 5% v / w and 10% v / w of diet.
Changes in body weight, food and water intake patterns of
rats in all the groups were noted throughout the experi-
mental period. At the end of the 30 days, rats were fasted
overnight and half the rats from each group were sub-
jected either to protocol I or to protocol II as described
below. Rats were heparinised (375 IU / 200 gms, i.p), and
0.5 h later rats were anesthetized with sodium pentobar-
bitone (60 mg / Kg, i.p) and euthanised.
Protocol I
Basal level of biochemical and histopathological studies
Immediately after euthanization, the hearts were rapidly
harvested, washed in ice cold saline, frozen in liquid
nitrogen and stored at -80°C until processed for estima-
tions of biochemical parameters. For histopathological
studies, heart was stored in 10% buffered formalin (pH
7.2).
Light micrograph of heart tissue Figure 3
Light micrograph of heart tissue. Rat heart supplemented with 5% v/w of dietary palm olein oil subjected to 20 min ischemia 
and 40 min of reperfusion (PO5 IR) showing mild edema with occasional loss of myofibre (H & E X 10).BMC Pharmacology 2004, 4:29 http://www.biomedcentral.com/1471-2210/4/29
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Group C: Normal diet fed rats (n = 8)
Group PO 5: 5% v / w palm olein oil supplemented diet
fed rats (n = 8)
Group PO 10:10% v / w palm olein oil supplemented diet
fed rats (n = 8)
Protocol II
Production of in vitro ischemic reperfusion injury
Immediately after euthanization, hearts were rapidly har-
vested, washed in ice-cold saline, and perfused with the
non-recirculating Langendorff's technique (Hufesco,
Hungary), under constant pressure mode with modified
Kreb Hensleit's buffer [18] containing [mM]: glucose
11.1; NaCl 118.5; NaHCO3 25; KCl 2.8; KH2PO4 1.2;
CaCl2  1.2; MgSO4  0.6, with a pH of 7.4. The buffer
solution equilibriated with 95% O2+ 5% CO2 was deliv-
ered to the aortic canula at 37°C and 65 mm Hg pressure.
Following 10 min. of equilibration period, hearts were
subjected to 20 min. of zero flow (global ischemia) and
40 min. of re-flow (reperfusion) [19,20].
Group C IR: Normal diet fed rats subjected to IR injury (n
= 8)
Group PO5 IR: 5% v/w palm olein oil supplemented diet
fed rats subjected to IR injury (n = 8)
Light micrograph of heart tissue Figure 4
Light micrograph of heart tissue. Rat heart supplemented with 10% v/w of dietary palm olein oil subjected to 20 min ischemia 
and 40 min of reperfusion (PO10 IR) with mild to moderate edema and occasional loss of myofibre (H & E X 10).BMC Pharmacology 2004, 4:29 http://www.biomedcentral.com/1471-2210/4/29
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Group PO10 IR: 10% v/w palm olein oil supplemented
diet fed rats subjected to IR injury (n = 8)
At the end of each experiment, heart was frozen in liquid
nitrogen and stored at -80°C until processed for estima-
tions of biochemical parameters. For histopathological
studies, heart was stored in 10% buffered formalin (pH
7.2).
Biochemical parameters
Myocardial TBARS [21]
Hearts were homogenized in 10% trichloroacetic acid
(TCA) at 4°C. 0.2 ml homogenate was pipetted into a test
tube, followed by addition of 0.2 ml of 8.1 % sodium
dodecyl sulphate (SDS), 1.5 ml of 30% acetic acid (pH-
3.5), 1.5 ml of 0.8% thiobarbituric acid (TBA) and vol-
ume was made upto 4.0 ml with DDW. Test tubes were
boiled at 95°C for 60 min. and then cooled. 1.0 ml of
DDW and 5.0 ml of n-butanol: pyridine (15:1 v / v) mix-
ture was added to the test tubes and centrifuge at the
4,000 × g for 10 min. The absorbance of developed colour
in organic layer was measured at 532 nm.
Commercially available 1, 1, 3, 3-tetraethoxypropane
(Sigma Chemicals) was used as a standard for MDA. Data
is expressed as nmol / mg protein.
Myocardial CAT [22]
Hearts were homogenized at 4°C (1:10) in 50 mmol/l
potassium phosphate buffer (pH- 7.4) and centrifuged at
3,000 × g for 10 min. Supernatant (50 µl) was added to a
3.0 ml cubette that contained 1.95 ml of 50 mM phos-
phate buffer (pH-7.0). Then1.0 ml of 30 mM hydrogen
peroxide was added and changes in absorbance were
measured for 30 sec. at 240 nm at an interval of 15 sec.
Catalase activity is expressed as units / mg protein as com-
pared to the standard.
Myocardial SOD [23]
Hearts were homogenized in 0.25 M tris sucrose buffer
and centrifuged at 10,000 × g for 15 min at 4°C. The
supernatant was fractionated by 50% ammonium sul-
phate and dialysed overnight. Aliquots of the supernatant
(100 µl) was added to sodium pyrophosphate buffer (pH-
8.3) followed by addition of 0.1 ml of 186 µM phenazine
methosulphate, 0.3 ml of 300 mM nitroblue tetrazolium
and 0.2 ml of 780 µM NADH. Reaction mixture was incu-
bated for 90 sec. at 30°C and stopped the reaction by add-
ing 1.0 ml of glacial acetic acid. 4.0 ml of n-butanol was
then added and centrifuged at 3,000 × g for 10 min. The
absorbance of organic layer was measured at 560 nm.
SOD activity is expressed as units / mg protein as com-
pared to the standard.
Myocardial GPx [24]
Hearts were homogenized at 4°C in 0.25 M phosphate
buffer saline (pH-7.0). Homogenate was centrifuged at
15,000 × g for 60 min. at 4°C and supernatant were
assayed for the GPx activity. GPx activity was in a 1.0 ml
cubette containing 400 µl of 0.25 M potassium phosphate
buffer (pH-7.0), 200 µl of sample, 100 µl of 10 mM GSH,
100  µl of 2.5 mM NADPH and 100 µl of glutathione
reductase (6 U / ml). Hydrogen peroxide (100 µl of 12
mM) was then added and change in absorbance was
measured at an interval of 1 min for 5 min at 366 nm. GPx
activity is expressed as units / mg protein as compared to
the standard.
Protein concentration was measured by Bradford method
[25].
Histopathological studies
Heart tissue was fixed in 10% buffered formalin, routinely
processed and embedded in paraffin. Paraffin sections (3
µm) were cut on glass slides and stained with hematoxylin
and eosin (H&E), periodic acid Schiff (PAS) reagent and
examined under a light microscope (Nikon, Japan). His-
topathological study was carried out by one of the authors
(AKD), blinded to the groups.
Statistical analysis
All values are expressed as mean ± SE. One way ANOVA
followed by Bonferroni test was applied to test for signifi-
cance of biochemical data of the different groups. Signifi-
cance is set at p < 0.05.
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PO10: rats fed with 10% v/w palm olein oil supplemented
diet; C: rats fed with normal diet; C IR: rats fed with nor-
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